Company Overview of BioRelix, Inc.
BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.
5 Science Park at Yale
401 Winchester Avenue
New Haven, CT 06511
Founded in 2005
Key Executives for BioRelix, Inc.
Similar Private Companies By Industry
|Izun Pharmaceuticals Corporation||United States|
|Mpex Pharmaceuticals, Inc.||United States|
|Numark Laboratories, Inc.||United States|
|Johnson Matthey Pharma Services Inc.||United States|
|K-V Pharmaceutical Company||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Philadelphia, PA | PwCPosted: Mar 19
- Harrisburg, PA | PwCPosted: Mar 19
- Annapolis, MD | InventivPosted: Apr 20
- Nashville, TN | InventivPosted: Apr 20
Sponsored Financial Commentaries
To contact BioRelix, Inc., please visit www.biorelix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.